Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Larson

Showing results (761-770 of 798) with videos related to

Pageof 80
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 16, 2016
Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk FactorsJoseph L Usset, Rama Raghavan, Jonathan P Tyrer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2014
Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancerFrancisco J Candido-dos-Reis, Honglin Song, Ellen L Goode, et al.
Blood Advances|February 24, 2026
Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphomaYucai Wang, Melissa C Larson, Steven R Hwang, et al.
Oncotarget|February 6, 2016
A targeted genetic association study of epithelial ovarian cancer susceptibilityMadalene Earp, Stacey J Winham, Nicholas Larson, et al.
Blood Advances|December 11, 2025
Benefit of Rituximab Maintenance After First-line Bendamustine-Rituximab in Patients with Mantle Cell LymphomaYucai Wang, Melissa C Larson, Steven R Hwang, et al.
Blood Cancer Journal|April 25, 2026
Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapyYucai Wang, Melissa C Larson, Steven R Hwang, et al.
Oncotarget|October 15, 2017
Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome lociDylan M Glubb, Sharon E Johnatty, Michael C J Quinn, et al.
British Journal of Cancer|July 8, 2015
Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association ConsortiumC M Nagle, S C Dixon, A Jensen, et al.
Cancer Causes & Control : CCC|March 5, 2013
Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studiesMette T Faber, Susanne K Kjær, Christian Dehlendorff, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 24, 2021
Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian CancerMichael C J Quinn, Karen McCue, Wei Shi, et al.
Pageof 80

Showing results (761-770 of 798) with videos related to

Sort By:
Pageof 80
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 16, 2016
Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk FactorsJoseph L Usset, Rama Raghavan, Jonathan P Tyrer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2014
Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancerFrancisco J Candido-dos-Reis, Honglin Song, Ellen L Goode, et al.
Blood Advances|February 24, 2026
Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphomaYucai Wang, Melissa C Larson, Steven R Hwang, et al.
Oncotarget|February 6, 2016
A targeted genetic association study of epithelial ovarian cancer susceptibilityMadalene Earp, Stacey J Winham, Nicholas Larson, et al.
Blood Advances|December 11, 2025
Benefit of Rituximab Maintenance After First-line Bendamustine-Rituximab in Patients with Mantle Cell LymphomaYucai Wang, Melissa C Larson, Steven R Hwang, et al.
Blood Cancer Journal|April 25, 2026
Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapyYucai Wang, Melissa C Larson, Steven R Hwang, et al.
Oncotarget|October 15, 2017
Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome lociDylan M Glubb, Sharon E Johnatty, Michael C J Quinn, et al.
British Journal of Cancer|July 8, 2015
Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association ConsortiumC M Nagle, S C Dixon, A Jensen, et al.
Cancer Causes & Control : CCC|March 5, 2013
Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studiesMette T Faber, Susanne K Kjær, Christian Dehlendorff, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 24, 2021
Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian CancerMichael C J Quinn, Karen McCue, Wei Shi, et al.
Pageof 80